Cited by 89Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchProtein purification and stability

Heparin-induced tau filaments are structurally heterogeneous and differ from Alzheimer's disease filaments

Fichou, Yann, Vigers, Michael, Goring, Andrew K., Eschmann, Neil A., Han, Songi·2018·Chemical Communications

Abstract

Alzheimer's disease (AD) is characterized by the presence of tau filaments in the brain whose structure was recently solved. The formation of AD filaments is routinely modeled in vitro by mixing tau with heparin. This study shows that heparin-induced tau filaments are markedly different from the AD filaments and are highly heterogeneous.

Integrity signals

Registry

Crossref · 10.1039/c8cc01355a

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The structures of heparin-formed fibrils vary from those in AD.

    “with structures varying from those in AD (54, 55)”

    From MAP2 caps tau fibrils and inhibits aggregation (2023) · cites this paper as [54]

  • The fibrils employed in the current study are known to have different folds.

    “The fibrils that were employed in the current study are known to have different folds.”

    From MAP2 caps tau fibrils and inhibits aggregation (2023) · cites this paper as [54]

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fichou, Y., Vigers, M., Goring, A. K., Eschmann, N. A., & Han, S.
Affiliations
University of California, Santa Barbara (US)
Corresponding author
Han, Songi
Venue
Chemical Communications
Published
2018
Volume
54
Issue
36
Pages
4573-4576
ISSN
  • 1359-7345 (ISSN-L)
  • 1364-548X
OpenAlex
W2797385707
Cited by
89
References
24
Citations by year
2026: 7 · 2025: 7 · 2024: 8 · 2023: 12 · 2022: 10 · 2021: 17 · 2020: 8 · 2019: 14 · 2018: 6
FWCI
7.74
Type
journal article
Language
en
Open access
closed
Locations
  • Chemical Communications (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (R01AG05605, R01GM116128)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
Keywords
tau filaments, heparin, Alzheimer's disease, tau aggregation, filament structure, structural heterogeneity
MeSH terms
Alzheimer Disease, Amino Acid Sequence, Amyloid, Heparin, Humans, Membrane Proteins, Peptide Fragments, Protein Binding, Pyrrolidines, Spin Labels, Thiosulfonic Acids, Molecular Structure, tau Proteins, Protein Structure, Quaternary, Protein Multimerization, Protein Aggregation, Pathological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review